Kitagawa Yukiko, Inoue Kaoru, Sasaki Shigeru, Hayashi Yasuhide, Matsuo Yoshinobu, Lieber Michael R, Mizoguchi Hideaki, Yokota Jun, Kohno Takashi
Biology Division, National Cancer Center Research Institute, Tokyo 1040045, Japan.
J Biol Chem. 2002 Nov 29;277(48):46289-97. doi: 10.1074/jbc.M208353200. Epub 2002 Sep 12.
To understand molecular pathways underlying 9p21 deletions, which lead to inactivation of the p16/CDKN2A, p14/ARF, and/or p15/CDKN2B genes, in lymphoid leukemia, 30 breakpoints were cloned from 15 lymphoid leukemia cell lines. Seventeen (57%) breakpoints were mapped at five breakpoint cluster sites, BCS-LL1 to LL5, each of <15 bp. Two breakpoint cluster sites were located within the ARF and CDKN2B loci, respectively, whereas the remaining three were located >100 kb distal to the CDKN2A, ARF, and CDKN2B loci. The sequences of breakpoint junctions indicated that deletions in the 11 (73%) cell lines were mediated by illegitimate V(D)J recombination targeted at the five BCS-LL and six other sites, which contain sequences similar to recombination signal sequences for V(D)J recombination. An extrachromosomal V(D)J recombination assay indicated that BCS-LL3, at which the largest number of breakpoints (i.e. five breakpoints) was clustered, has a V(D)J recombination potential 150-fold less than the consensus recombination signal sequence. Three other BCS-LLs tested also showed V(D)J recombination potential, although it was lower than that of BCS-LL3. These results indicated that illegitimate V(D)J recombination, which was targeted at several ectopic recombination signal sequences widely distributed in 9p21, caused a large fraction of 9p21 deletions in lymphoid leukemia.
为了解导致p16/CDKN2A、p14/ARF和/或p15/CDKN2B基因失活的9p21缺失在淋巴白血病中的分子机制,从15个淋巴白血病细胞系中克隆了30个断点。17个(57%)断点定位于5个断点簇位点,即BCS-LL1至LL5,每个位点小于15bp。其中两个断点簇位点分别位于ARF和CDKN2B基因座内,而其余三个位于CDKN2A、ARF和CDKN2B基因座远端超过100kb处。断点连接序列表明,11个(73%)细胞系中的缺失是由靶向5个BCS-LL和其他6个位点的异常V(D)J重组介导的,这些位点含有与V(D)J重组信号序列相似的序列。一项染色体外V(D)J重组分析表明,断点聚集数量最多(即5个断点)的BCS-LL3的V(D)J重组潜力比共有重组信号序列低150倍。另外三个测试的BCS-LL也显示出V(D)J重组潜力,尽管低于BCS-LL3。这些结果表明,靶向广泛分布于9p21的几个异位重组信号序列的异常V(D)J重组导致了淋巴白血病中大部分的9p21缺失。